FDA Launches New 'Safe Use Initiative' to Reduce Medication Errors
by Enterprise Labeling on Nov 5, 2009 • 2:04 pm No CommentsI go to the U.S. Food and Drug Administration (FDA) website almost every day to glimpse their recent news releases. That’s because sometimes their announcements don’t seem to get much pick up in the usual places. Yesterday they issued this news release. The headline is: FDA Unveils Safe Use Initiative that Targets Preventable Harm from Medication Use. It is short and not very detailed and so it is difficult to know from just this where the new program fits in to other FDA initiatives to improve overall patient safety . . . like patient bedside barcoding, Unique Device Identification (UDI), and GS1-based overall healthcare product and device labeling.
Even so, if you’re in the pharmaceutical industry and haven’t seen this news, it is probably relevant to your future business interests. To provide some additional detail, I decided to drill down and find the full report, referenced in the news release, titled, “FDA’s Safe Use Initiative – Collaborating to Reduce Preventable Harm from Medicines.” It is a 25-page report. If nothing else, you may want to review the ‘Executive Summary.
Related posts:
- GS1 US and 55 Foodservice Companies Launch Major Initiative
- June 10 Web Seminar on Hospital Barcoding and Medication Errors
- GS1 North America in Great Collaboration With VICS to Reduce 'Empty Miles'
- GS1 Hong Kong Launches Consumer Product Authentication Solution
- Will it take an Act of Congress to make Drugs Safe?
GHS and Regulatory Labeling Challenges in the New Era 
